How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Capitol Hill

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Guest Editorial

Building cancer care resilience through international observerships: Lessons from Ukraine

Clinical Trials & Tribulations

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention

Cancer Policy

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

“Forward funding” NIH budget plan would make competing for grants much harder

Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored

NIH Director Jay Bhattacharya launches a podcast

FDA to issue “national priority vouchers” to companies supporting U.S. interests

Clinical Roundup

NCCN announces virtual tool for navigating guidelines

City of Hope launches AI tool to reduce burden of cancer care

Rucaparib maintenance therapy demonstrates PFS benefit for HRD-negative and HRD-positive ovarian cancer

Duvelisib + romidepsin combination effective for T-cell lymphoma patients, Mass General Brigham study shows

VCU Massey researchers discover TAF2 gene plays a pivotal role in HCC

Mayo Clinic researchers use biobanking tissue to better characterize ovarian cancer origins

In The Clinic

Trials & Tribulations

Optimizing dosing of expensive and toxic oncology drugs: Making America healthier

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Free

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Trials & Tribulations

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Trials & Tribulations

The other side of the patient portal: Reflections from a cancer center leader

Latest Issue

Read the latest issue

DOWNLOAD THE PDF

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Jul 2025

2025 Best of ASCO Minneapolis

Sep 2025

NCCN Oncology Policy Summit: The Evolving Artificial Intelligence Landscape in Cancer Care

Data Jamboree: Enhancing Childhood Cancer Data Sharing and Utility

Third Annual Data Sharing Symposium: How Data Advances the Impact of Cancer Research

Oct 2025

NCCN 2025 Annual Congress: Hematologic Malignancies™️

View All Events

Conversations with The Cancer Letter

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Contributors

Donald L. "Skip" Trump, MD

Federal funding cutbacks undermine advances in cancer research and treatment
What would Richard Nixon and Ted Kennedy think?

Linda Malkas, PhD

From “undruggable” target to clinical potential: The journey of AOH1996

City of Hope

Insights from ASCO 2025: Real-world evidence drives clinical decision-making

Hope S. Rugo, MD

Reimagining cancer care for a new generation of patients

Trending Stories

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”
How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
In the Headlines: What if curing diseases was treated like a business?
At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”
As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Recent Issues

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Building cancer care resilience through international observerships: Lessons from Ukraine

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

“Forward funding” NIH budget plan would make competing for grants much harder

Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored

NIH Director Jay Bhattacharya launches a podcast

FDA to issue “national priority vouchers” to companies supporting U.S. interests

NCCN announces virtual tool for navigating guidelines

City of Hope launches AI tool to reduce burden of cancer care

Rucaparib maintenance therapy demonstrates PFS benefit for HRD-negative and HRD-positive ovarian cancer

Duvelisib + romidepsin combination effective for T-cell lymphoma patients, Mass General Brigham study shows

VCU Massey researchers discover TAF2 gene plays a pivotal role in HCC

Mayo Clinic researchers use biobanking tissue to better characterize ovarian cancer origins

Optimizing dosing of expensive and toxic oncology drugs: Making America healthier

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

The other side of the patient portal: Reflections from a cancer center leader

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Donald L. "Skip" Trump, MD

Linda Malkas, PhD

City of Hope

Hope S. Rugo, MD

Never miss an issue!

Login